Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Intensive Care
Published in: Annals of Intensive Care 1/2023

Open Access 01-12-2023 | Review

Trends in ICU mortality and underlying risk over three decades among mechanically ventilated patients. A group level analysis of cohorts from infection prevention studies

Author: James C. Hurley

Published in: Annals of Intensive Care | Issue 1/2023

Login to get access

Abstract

Background

Has either the underlying risk or the mortality incidence among ICU patients receiving mechanical ventilation (MV) in the literature changed in recent decades? Interpreting ICU mortality trends requires an adjusted analysis accounting for changes in underlying patient risk.

Methods

Control and intervention groups from 147 randomized concurrent control trials (RCCT) of various VAP prevention interventions, as listed primarily within 13 Cochrane reviews and 63 observational studies listed primarily within four systematic reviews. Eligible studies were those including ICU patients with > 50% of patients receiving > 24 h of MV with mortality data available. ICU mortality (censored day 21 or before) or late (after day 21) mortality together with group-mean age, and group-mean APACHE II scores were extracted from all groups. These incidences were summarized in five meta-regression models versus publication year being variously adjusted for age, APACHE II scores, type of study intervention and other group level parameters.

Results

Among 210 studies published between 1985 and 2021, 169 being found in systematic reviews, the increase per decade in mean mortality incidence, group-mean APACHE II scores, and group-mean age, were < 1 percentage point (p = 0.43), 1.83 (95% CI; 0.51–3.15) points, and 3.9 (95% CI; 1.1–6.7) years, respectively. Only in the model with risk adjustment for both group-mean age and group-mean APACHE II score was a significant decline in mortality apparent. In all models, the mortality incidence among concurrent control groups of decontamination studies was paradoxically five percentage points higher than benchmark and showed greater dispersion.

Conclusion

Mortality incidence has changed little over 35 years among ICU infection prevention studies whilst the patient age and underlying disease severity, measured as APACHE II, have both increased. The paradoxically high mortality among concurrent control groups within studies of decontamination methods of infection prevention remains unaccounted for.
Appendix
Available only for authorised users
Literature
1.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRefPubMed
2.
Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323:1478–87.CrossRefPubMedPubMedCentral
3.
Hurley JC. Selective digestive decontamination, a seemingly effective regimen with individual benefit or a flawed concept with population harm? Crit Care. 2021;25(1):323.CrossRefPubMedPubMedCentral
4.
5.
Oostdijk EA, de Smet AM, Blok HE, et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med. 2010;181:452–7.CrossRefPubMed
6.
Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med. 1984;10:185–92.CrossRefPubMed
7.
de Smet AMGA, Kluytmans JAJW, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20–31.CrossRefPubMed
8.
Wittekamp BH, Plantinga NL, Cooper BS, et al. Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients: a randomized clinical trial. JAMA. 2018;320:2087–98.CrossRefPubMedPubMedCentral
9.
The SuDDICU Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation: a randomized clinical trial. JAMA. 2022;328:1911–21.CrossRefPubMedCentral
10.
Toews I, George AT, Peter JV, Kirubakaran R, Fontes LES, Ezekiel JPB, Meerpohl JJ. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD008687.
11.
Lewis SR, Schofield-Robinson OJ, Alderson P, Smith AF. Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unit. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD012276.
12.
Padilla PF, Martínez G, Vernooij RW, Urrútia G, i Figuls MR, Cosp XB. Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults. Cochrane Database of Systematic Reviews 2019(10).
13.
Alkhawaja S, Martin C, Butler RJ, Gwadry‐Sridhar F. Post‐pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults. Cochrane Database of Systematic Reviews. 2015(8).
14.
Solà I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD004581.
15.
Gillies D, Todd DA, Foster JP, Batuwitage BT. Heat and moisture exchangers versus heated humidifiers for mechanically ventilated adults and children. Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD004711.
16.
Wang L, Li X, Yang Z, Tang X, Yuan Q, Deng L, Sun X. Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD009946.
17.
Tokmaji G, Vermeulen H, Müller MCA, Kwakman PHS, Schultz MJ, Zaat SAJ. Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD009201.
18.
Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, Kollef MH, Crooks NH, Deng X. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD009066.
19.
Hua F, Xie H, Worthington HV, Furness S, Zhang Q, Li C. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD008367.
20.
Zhao T, Wu X, Zhang Q, Li C, Worthington HV, Hua F. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No.: CD008367.
21.
Liberati A, D’Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD000022.
22.
Minozzi S, Pieri S, Brazzi L, Pecoraro V, Montrucchio G, D'Amico R. Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD000022.
23.
Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184–93.CrossRefPubMed
24.
Melsen WG, Rovers MM, Bonten MJM. Ventilator-associated pneumonia and mortality: A systematic review of observational studies. Crit Care Med. 2009;37:2709–18.PubMed
25.
Agrafiotis M, Siempos II, Ntaidou TK, Falagas ME. Attributable mortality of ventilator-associated pneumonia: a meta-analysis. Internat J Tuberculosis Lung Dis. 2011;15(9):1154–63.CrossRef
26.
Pileggi C, Mascaro V, Bianco A, Nobile CG, Pavia M. Ventilator bundle and its effects on mortality among ICU patients: a meta-analysis. Crit Care Med. 2018;46(7):1167–74.CrossRefPubMed
27.
Hammond NE, Myburgh J, Seppelt I, Garside T, Vlok R, Mahendran S, Adigbli D, Finfer S, Gao Y, Goodman F, Guyatt G. Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA. 2022;328:1922–34.CrossRefPubMedPubMedCentral
28.
Hurley JC. Discrepancies in control group mortality rates within studies assessing topical antibiotic strategies to prevent ventilator-associated pneumonia: an umbrella review. Crit Care Explor. 2020;2(1):e0076.CrossRefPubMedPubMedCentral
29.
30.
Massart N, Wattecamps G, Moriconi M, Fillatre P. Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis. Eur J Clin Microbiol Infect Dis. 2021;40(8):1673–80.CrossRefPubMedPubMedCentral
31.
Hurley JC, Guidet B, Offenstadt G, Maury E. Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit Care. 2012;16:1–3.CrossRef
32.
Hurley JC. Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves. J Endotoxin Res. 2003;9(5):271–9.CrossRefPubMed
33.
Zimmerman JE, Kramer AA, Knaus WA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17:1–9.CrossRef
34.
Fuchs L, Novack V, McLennan S, Celi LA, Baumfeld Y, Park S, Howell MD, Talmor DS. Trends in severity of illness on ICU admission and mortality among the elderly. PLoS ONE. 2014;9: e93234.CrossRefPubMedPubMedCentral
35.
Moran JL, Bristow P, Solomon PJ, George C, Hart GK, Australian and New Zealand Intensive Care Society Database Management Committee (ADMC). Mortality and length-of-stay outcomes, 1993–2003, in the binational Australian and New Zealand intensive care adult patient database. Crit Care Med. 2008;36:46–61.CrossRefPubMed
36.
Moran JL, Solomon PJ, ANZICS Centre for Outcome and Resource Evaluation (CORE) of the Australian, New Zealand Intensive Care Society (ANZICS). Mortality and intensive care volume in ventilated patients from 1995 to 2009 in the Australian and New Zealand binational adult patient intensive care database. Crit Care Med. 2012;40:800–12.CrossRefPubMed
37.
Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42:625–31.CrossRefPubMedPubMedCentral
38.
Luhr R, Cao Y, Soederquist B, Cajander S. Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002––2017. Crit Care. 2019;23:1–9.CrossRef
39.
de Grooth HJ, Parienti JJ, Postema J, Loer SA, Oudemans-van Straaten HM, Girbes AR. Positive outcomes, mortality rates, and publication bias in septic shock trials. Intensive Care Med. 2018;44:1584–5.CrossRefPubMed
40.
Juschten J, Tuinman PR, Guo T, Juffermans NP, Schultz MJ, Loer SA, Girbes AR, de Grooth HJ. Between-trial heterogeneity in ARDS research. Intensive Care Med. 2021;47(4):422–34.CrossRefPubMedPubMedCentral
41.
Popovich MJ. If most intensive care units are graduating with honors, is it genuine quality or grade inflation? Crit Care Med. 2002;30:2145–6.CrossRefPubMed
42.
Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thoracic Dis. 2020;12(Suppl 1):S89.CrossRef
43.
Friedrich JO, Harhay MO, Angus DC, Burns KE, Cook DJ, Fergusson DA, et al. Mortality as a measure of treatment effect in clinical trials recruiting critically ill patients. Crit Care Med. 2023;51(2):222–30.CrossRefPubMed
44.
de Rooij SE, Govers A, Korevaar JC, Abu-Hanna A, Levi M, De Jonge E. Short-term and long-term mortality in very elderly patients admitted to an intensive care unit. Intensive Care Med. 2006;32:1039–44.CrossRefPubMed
45.
Atramont A, Lindecker-Cournil V, Rudant J, Tajahmady A, Drewniak N, Fouard A, Singer M, Leone M, Legrand M. Association of age with short-term and long-term mortality among patients discharged from intensive care units in France. JAMA Netw Open. 2019;2(5): e193215.CrossRefPubMedPubMedCentral
46.
Klompas M, Speck K, Howell MD, et al. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med. 2014;174:751–61.CrossRefPubMed
47.
Hurley JC, Opal SM. Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependent. J Innate Immun. 2013;5(6):555–64.CrossRefPubMedPubMedCentral
48.
Hurley JC. Prophylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection? Antimicrob Agents Chemother. 1995;39:941–7.CrossRefPubMedPubMedCentral
49.
Roquilly A, Chanques G, Lasocki S, Foucrier A, Fermier B, De Courson H, Carrie C, Danguy des Deserts M, Gakuba C, Constantin JM, Lagarde K. Implementation of French recommendations for the prevention and the treatment of hospital-acquired pneumonia: a cluster-randomized trial. Clin Infect Dis. 2021;73(7):e1601–10.CrossRefPubMed
50.
Silvestri L, de la Cal MA, van Saene HK. Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med. 2012;38:1738–50.CrossRefPubMed
51.
Hurley JC. Structural equation modeling the “control of gut overgrowth” in the prevention of ICU-acquired Gram-negative infection. Crit Care. 2020;24:1–2.CrossRef
52.
53.
Hurley JC. Establishing the safety of selective digestive decontamination within the ICU population: a bridge too far? Trials. 2023;24(1):1–5.CrossRef
Metadata
Title
Trends in ICU mortality and underlying risk over three decades among mechanically ventilated patients. A group level analysis of cohorts from infection prevention studies
Author
James C. Hurley
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2023
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-023-01159-0

Other articles of this Issue 1/2023

Annals of Intensive Care 1/2023 Go to the issue

Research

Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Research

Sex difference in the risk of extubation failure in ICUs

Letter to the Editor

Extubation during extracorporeal membrane oxygenation in severe acute respiratory distress syndrome: time for a paradigm shift?

Research

Association of pronounced elevation of NET formation and nucleosome biomarkers with mortality in patients with septic shock

Research

Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study

Research

High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis